Here is what you need to know about your Glaucoma Teleconsultation with Dr Shibal Bhartiya. You have glaucoma reports in…
Author: Dr Shibal Bhartiya
Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, and Clinical Director at Marengo Asia Hospitals, Gurugram. She has 25+ years of experience in glaucoma diagnosis, treatment, and surgery, with a focus on early detection, personalised care, and long-term vision protection. Her other focus areas include neuro-ophthalmology and ocular surfaced diseases. Trained from the prestigious University of Geneva, AIIMS (New Delhi) and MAMC (New Delhi) she is known for her compassionate, and ethical practice in Gurgaon.
She has authored more than 200 peer-reviewed articles, including 94 PubMed-indexed publications and edited 28 textbooks in ophthalmology. She serves as Executive Editor of the Journal of Current Glaucoma Practice and Editor-in-Chief of Clinical and Experimental Vision and Eye Research.
Her research spans the biology of glaucoma, surgical outcomes, health equity, quality of life, and emerging diagnostics. She collaborates with leading institutions including Mayo Clinic, Zhongshan Ophthalmic Centre, and Singapore National Eye Centre.
In addition to comprehensive eye care for adults and children, she especially offers independent glaucoma second opinions for patients across India and abroad, and works in partnership with referring eye doctors to support complex and long-term glaucoma care as well as management of neuro-ophthalmological conditions.
Myopia Prevention in Children
Dr Shibal Bhartiya explains strategies for myopia prevention children: myopia progression prevention glasses, low dose atropine, and time spent outdoors….
Niacinamide and Glaucoma: Can Vitamin B3 Protect Your Optic Nerve?
Niacinamide holds promise as a potential neuroprotective agent in glaucoma, says the AAO and AGS joint position statement on Niacinamide….
GLP-1 Agonists and Eye Health: What You Need to Know Before Starting Ozempic or Mounjaro
GLP-1 receptor agonists, approved for type 2 diabetes management and weight loss, can affect your vision. There is a risk…
Steroid Induced Glaucoma
Steroids carry a risk that many patients, and even some prescribing doctors, overlook. They can silently raise the pressure inside…